Smit M, Dohle G R, Hop W C J, Wildhagen M F, Weber R F A, Romijn J C
Andrology Unit of the Department of Urology, Erasmus MC, Rotterdam, The Netherlands.
Int J Androl. 2007 Feb;30(1):48-55. doi: 10.1111/j.1365-2605.2006.00710.x. Epub 2006 Nov 29.
Determination of sperm DNA fragmentation, as assessed by the sperm chromatin structure assay (SCSA), has become an important tool for the evaluation of semen quality. The aim of the present study was to describe the biological variation of sperm DNA fragmentation in men attending an andrology clinic and to identify clinical correlates of the biological variation of sperm DNA fragmentation. For this study, two consecutive semen samples from 100 patients attending our andrology outpatient clinic were subjected to semen analysis, performed in parallel according to WHO guidelines and by SCSA. A good agreement between pairs of samples was found for SCSA-derived variables, as indicated by a significantly lower median coefficient of variation (CV) of the DNA Fragmentation Index (DFI) and the high DNA stainability (HDS) compared with WHO semen parameters. In half of the men attending our andrology clinic, however, the individual biological variation of DFI and HDS, expressed as CV of two samples, exceeded 10%. Dysregulation of spermatogenesis, as seen as testicular insufficiency or varicocele, was not associated with increased variability of DFI or HDS. A backward multiple linear regression analysis, however, indicated that the biological variation of DFI may be more profound in men with characteristics of normal spermatogenesis. In conclusion, we confirm previous reports that sperm DNA fragmentation has a lower biological variability than classical semen parameters. We hypothesize that the sperm chromatin structure may be more influenced in patients with normal spermatogenesis, whereas in men with disturbed spermatogenesis, the chromatin structure may be already so impaired that the effect of unidentified factors leading to variability of sperm DNA fragmentation in time may not be as profound.
通过精子染色质结构分析(SCSA)评估精子DNA片段化,已成为评估精液质量的一项重要工具。本研究的目的是描述男科门诊男性精子DNA片段化的生物学变异,并确定精子DNA片段化生物学变异的临床相关因素。在本研究中,对100名到我们男科门诊就诊患者的两份连续精液样本进行了精液分析,按照世界卫生组织(WHO)指南并通过SCSA并行进行。与WHO精液参数相比,DNA片段化指数(DFI)和高DNA染色性(HDS)的中位数变异系数(CV)显著更低,这表明SCSA衍生变量在样本对之间具有良好的一致性。然而,在我们男科门诊就诊的男性中,有一半人的DFI和HDS个体生物学变异(以两份样本的CV表示)超过了10%。生精功能失调,如睾丸功能不全或精索静脉曲张,与DFI或HDS变异性增加无关。然而,向后多元线性回归分析表明,在具有正常生精特征的男性中,DFI的生物学变异可能更为显著。总之,我们证实了之前的报道,即精子DNA片段化的生物学变异性低于经典精液参数。我们推测,在生精正常的患者中,精子染色质结构可能受影响更大,而在生精功能紊乱的男性中,染色质结构可能已经严重受损,以至于导致精子DNA片段化随时间变化的未知因素的影响可能不那么显著。